References
- Wu X, Fu B, Chen L, Feng Y. Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China. J Med Virol. 2020;92:1795-1796. https://doi.org/10.1002/jmv.25904
- Pollan M, Perez-Gomez B, Pastor-Barriuso R, Oteo J, Hernan MA, Perez-Olmeda M, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020;396:535-544. https://doi.org/10.1016/S0140-6736(20)31483-5
- Doi A, Iwata K, Kuroda H, Hasuike T, Nasu S, Kanda A, et al. Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: a cross-sectional study. Clin Epidemiol Glob Health. 2021;11:100747. https://doi.org/10.1016/j.cegh.2021.100747
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239-1242. https://doi.org/10.1001/jama.2020.2648
- Han MS, Choi EH, Chang SH, Jin BL, Lee EJ, Kim BN. Clinical characteristics and viral RNA detection in children with coronavirus disease 2019 in the Republic of Korea. JAMA Pediatr. 2021;175:73-80. https://doi.org/10.1001/jamapediatrics. 2020.3988
- Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J. SARS-CoV-2 infection in children. N Engl J Med. 2020;382:1663-1665. https://doi.org/10.1056/NEJMc2005073
- Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z. Epidemiology of COVID-19 among children in China. Pediatr. 2020;145:e20200702. https://doi.org/10.1542/peds.2020-0702
- Liu P, Cai J, Jia R, Xia S, Wang X, Cao L, et al. Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19. Emerg Microbes Infect. 2020;9:1254-1258. https://doi.org/10.1080/22221751.2020.1772677
- Hua CZ, Miao ZP, Zheng JS, Huang Q, Sun QF, Lu HP, et al. Epidemiological features and viral shedding in children with SARS-CoV-2 infection. J Med Virol. 2020;92:2804-2812. https://doi.org/10.1002/jmv.26180
- Health Information and Quality Authority (HIQA). Evidence summary of the immune response following infection with SARS-CoV-2 or other human coronaviruses [Internet]. Cork: Health Information and Quality Authority. 2020 [cited 2022 June 16]. Available from: https://www.hiqa.ie/sites/default/files/2020-08/Evidence-summary_SARS-CoV-2-immune-response.pdf
- Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200-1204. https://doi.org/10.1038/s41591-020-0965-6
- Ibarrondo FJ, Fulcher JA, Goodman-Meza D, Elliott J, Hofmann C, Hausner MA, et al. Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild covid-19. N Engl J Med. 2020;383:1085-1087. https://doi.org/10.1056/NEJMc2025179
- Seow J, Graham C, Merrick B, Acors S, Pickering S, Steel KJA, et al. Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. Nat Microbiol. 2020;5:1598-1607. https://doi.org/10.1038/s41564-020-00813-8
- Mercado-Reyes MM, Daza M, Pacheco A, Meneses-Gil MX, Galindo M, Catama J, et al. Seroprevalence of SARS-CoV-2 antibodies in children and adolescents: results from a population based survey in 10 Columbian cities. Glob Pediatr Health. 2022;9: 2333794X221085385. https://doi.org/10.1177/2333794X221085385
- Lewin A, Therrien R, Serres GD, Gregoire Y, Perreault J, Drouin M, et al. SARS-CoV-2 seroprevalence among blood donors in Quebec and analysis of symptoms associated with seropositivity: a nested cases-control study. Can J Public Health. 2021;112:576-586. https://doi.org/10.17269/s41997-021-00531-6
- James K. University of Calgary. Alberta childhood COVID-19 cohort (AB3C) aim 3: longitudinal sero-epidemiology study first interim report January 31, 2021 [Internet] Calgery: University of Calgary PRISM: University of Calgary's Digital Repository. 2021 [cited 2022 June 10]. Available from: https://prism.ucalgary.ca/bitstream/handle/1880/113084/AB3C%Aim%3%1st%Interim%Report-final.pdf?sequence=5&isAllowed=y
- Manny E, Carroll A, Charlton C, Robinson J, Subbarao P, Azad MB, et al. Increased mask use and fewer gatherings associated with lower SARS-CoV-2 seropositivity among young school-age children, Preprints with THE LANCET 2020 [Internet] SSRN. [cited 2022 June 10]. Available from: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3728570
- Tonshoff B, Muller B, Elling R, Renk H, Meissner P, Hengel H, et al. Prevalence of SARS-CoV-2 infection in children and their parents in southeast Germany. JAMA Pediatr. 2021;175:586-593. https://doi.org/10.1001/jamapediatrics.2021.0001
- Lachassinne E, de Pontual L, Caseris M. Lorrot M, Guilluy C, Naud A, et al. SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study. Lancet Child Adolesc Health. 2021;5:256-264. https://doi.org/10.1016/S2352-4642(21)00024-9
- Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396:313-319. https://doi.org/10.1016/S0140-6736(20)31304-0
- Ulyte A, Radtke T, Abela IA, Haile SR, Berger C, Huber M. Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools. BMJ. 2021;372:n616. https://doi.org/10.1136/bmj.n616
- Waterfield T, Watson C, Moore R, Ferris K, Tonry C, Watt A, et al. Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study. Arch Dis Child. 2021;106: 680-686. https://doi.org/10.1136/archdischild-2020-320558
- Smith BK, Janowski AB, Danis JE, Harvey IB, Zhao H, Dai YN, et al. Seroprevalence of SARS-CoV-2 antibodies in children and adults in St. Louis, Missouri, USA, mSphere. 2021;6:e01207-20. https://doi.org/10.1128/mSphere.01207
- Bloomfield M, Pospisilova I, Cabelova T, Sediva A, Ibrahimova M, Borecka K, et al. Searching for COVID-19 antibodies in Czech children-a needle in the haystack. Front Pediatr. 2020;8:597736. https://doi.org/10.3389/fped.2020.597736
- Murhekar MV, Bhatnagar T, Selvaraju S, Saravanakumar V, Thangraj JWV, Shah N, et al. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey. Lancet Glob Health. 2021; 9:e257-266. https://doi.org/10.1016/S2214-109X(20)30544-1
- Venkataraman A, Balasubramanian S, Putilibai S, Raj SL, Amperayani S, Senthilnathan S, et al. Correlation of SARS-CoV-2 serology and clinical phenotype amongst hospitalised children in a tertiary children's hospital in India. J Trop Pediatr. 2021;67: fmab015. https://doi.org/10.1093/tropej/fmab015
- Misra P, Kant S, Guleria R, Rai SK, Kishore S, Baidya S, et al. Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. J Family Med Prim Care. 2022;11:2816-2823. https://doi.org/10.4103/jfmpc.jfmpc_2274_21
- Zinszer K, McKinnon B, Bourque N, Pierce L, Saucier A, Otis A, et al. Seroprevalence of SARS-CoV-2 antibodies among children in school and day care in Montreal, Canada. JAMA Netw Open. 2021; 4: 2135975. https://doi.org/10.1001/jamanetworkopen.2021.35975
- Richard A, Wisniak A, Perez-Saez J, Garrison-Desany H, Petrovic D, Piumatti G, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study. Scand J Public Health. 2022;50:124-135. https://doi.org/10.1177/14034948211048050
- Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8:813-822. https://doi.org/10.1016/S2213-8587(20)30272-2
- Rabbone I, Schiaffini R, Cherubini V, Maffeis C, Scaramuzza A, Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care. 2020;43:2870-2872. https://doi.org/10.2337/dc20-1321
- Verma A, Rajput R, Verma S, Balania VKB, Jangra B. Impact of lockdown in COVID 19 on glycemic control in patients with type 1 diabetes mellitus. Diabetes Metab Syndr. 2020;14:1213-1216. https://doi.org/10.1016/j.dsx.2020.07.016
- Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Netw Open. 2021;4: e2111182. https://doi.org/10.1001/jamanetworkopen.2021.11182
- Cabezudo-Garcia P, Ciano-Petersen NL, Mena-Vazquez N, Pons-Pons G, Castro-Sanchez MV, Serrano-Castro PJ. Incidence and case fatality rate of COVID-19 in patients with active epilepsy. Neurology. 2020;95:e1417-e1425. https://doi.org/10.1212/WNL.0000000000010033
- Williams N, Radia T, Harman K, Agrawal P, Cook J, Gupta A. COVID- 19 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities. Eur J Pediatr. 2021;180:689-697. https://doi.org/10.1007/s00431-020-03801-6
- Pranata R, Lim MA, Yonas E, Vania R, Lukito AA, Siswanto B, et al. Body mass index and outcome in patients with COVID-19: a dose-response meta-analysis. Diabetes Metab. 2021;47:101178. https://doi.org/10.1016/j.diabet.2020.07.005
- National Centres on Birth Defects and Developmental Disabilities (NCBDDD). Data and statistics on children's mental health. [Internet]. Atlanta: Centers for Disease Control and Prevention. 2022 [cited 2022 June 15]. Available from: https://www.cdc.gov/childrensmentalhealth/data.html
- Sidhu SK, Singh K, Tuli AK, Bigdelitabar S, Jairath M. Prevalence of novel corona virus (severe acute respiratory syndrome Coronavirus 2) and its uncertain future in the different regions of Punjab. Indian J Public Health. 2022;66:45-48. https://doi.org/10.4103/ijph.ijph_1793_21
- Davies NG, Klepac P, Liu Y, Prem K, Jit M; CMMID COVID-19 working group, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med. 2020;26:1205-1211. https://doi.org/10.1038/s41591-020-0962-9
- Nickbakhsh S, Ho A, Marques DFP, McMenamin J, Gunson RN, Murcia PR. Epidemiology of seasonal coronaviruses: establishing the context for the emergence of coronavirus disease 2019. J Infect Dis. 2020;222:17-25. https://doi.org/10.1093/infdis/jiaa185
- Bunyavanich S, Do A, Vicencio A. Nasal gene expression of angiotensin- converting enzyme 2 in children and adults. JAMA. 2020;323:2427-2429. https://doi.org/10.1001/jama.2020.8707